Hacker News Reader

Comment by njoubert | Hacker News Reader

You're painting an unfairly one-sided picture here, as so many pro-psychedelic people do. These are highly potent chemicals that also have negative physical and psychological effects. It's not as simple as "these substances cure a condition and the fear of psychedelics keep them repressed". You are saying the equivalent of the college stoner friend saying "you can't get addicted!" about weed. Even this article points to fatal heartbeat irregularities as a dangerous side effect that has limited ibogaine's study.

View on HN

Look at the analogs act, and the banning of salvia in many US states, and tell me that such things as negative externalities are actually weighted in the decision to ban things. Look at 2CB. It was banned for having chemical proximity to DOB, which is banned for having chemical proximity to DOM. 2CB was banned for the entire justification of "posing a risk to the public health." Where? How? I've never found data published to justify this scheduling, other than chemical proximity. Why was DOM banned? Posing a risk to the public health. Again, I can find no data.

Salvia is even more clowning. Republican legislators heard that it's a more potent psychedelic than LSD and rushed to ban it without even knowing what "potency" means for such a comparison. This has led to such beautiful pieces of law as Florida (I believe) banning salvia divinorum and all chemical derivatives thereof. Salvia divinorum is a plant. There are no chemical derivatives. They should have specified its principle component, salvinorin A, and its derivatives. These banning were made entirely out of moral panic, with not even a modicum of pharmacological or chemical understanding.

2C-B is one of the few drugs on my "want to try" list. I imagine I won't see a reliably uncontaminated version in my lifetime though.

I agree, it's important to soberly identify and weigh all the risks associated with any treatment.

But it's also important to recognize medical risk alone is not what has stopped the serious evaluation of entheogenic or hallucinogenic substances.

Ibogaine's safety profile is pretty good, there is a reason it is legal in other countries. The cardiac risk factors can be mitigated with appropriate screening, and of course, it should not be consumed with other substances with unsafe drug interactions. To the extent that Ibogaine fatalities have occurred, they are largely attributable to these two factors. In this respect, it is not especially different from plenty of other OTC and prescription drugs.

This is not to say that Ibogaine has zero risk for either physical or psychological harm---this cannot be said about very many perscription drugs either. However, given its efficacy for treating opiod use disorders alone, along with its safety profile, there is no logical reason that it should be out of reach for mental health professionals, let alone a schedule 1 substance.

This would be a great rebuttal if I said “this is why ibogaine isn’t approved and used broadly!” but I didn’t. I said this is why we don’t really understand Ibogaine.

The action proposed in the article is: more trials

Good thing nobody is forcing you to consume anything then.

Reply on news.ycombinator.com